Aflibercept/bevacizumab/triamcinoloneLack of efficacy during treatment of macular oedema secondary to central retinal vein occlusion: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1896卷 / 1期
关键词：
D O I：
10.1007/s40278-022-10817-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：26 / 26
相关论文
共 50 条
  • [41] Efficacy of Intravitreal Bevacizumab Injection for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion
    Celik, Erkan
    Turkoglu, Elif Betul
    Aksoy, Nilgun
    Cakir, Burcin
    Dogan, Emine
    Alagoz, Gursoy
    OPHTHALMOLOGICA, 2014, 232 : 92 - 92
  • [42] Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion: more data required
    K Hu
    S E Horgan
    R R Sivaraj
    K Avgikos
    Eye, 2010, 24 : 194 - 194
  • [43] Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion
    Tao, Y.
    Hou, J.
    Jiang, Y-R
    Li, X-X
    Jonas, J. B.
    EYE, 2010, 24 (05) : 810 - 815
  • [44] Drug treatment of macular oedema secondary to central retinal vein occlusion: a network meta-analysis
    Ford, John A.
    Shyangdan, Deepson
    Uthman, Olalekan A.
    Lois, Noemi
    Waugh, Norman
    BMJ OPEN, 2014, 4 (07):
  • [45] Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion
    Y Tao
    J Hou
    Y-R Jiang
    X-X Li
    J B Jonas
    Eye, 2010, 24 : 810 - 815
  • [46] Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis
    Sangroongruangsri, Sermsiri
    Ratanapakorn, Tanapat
    Wu, Olivia
    Anothaisintawee, Thunyarat
    Chaikledkaew, Usa
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (09) : 903 - 916
  • [47] One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion
    Wang, Nancy
    Hunt, Adrian
    Nguyen, Vuong
    Shah, Janika
    Fraser-Bell, Samantha
    McAllister, Ian
    Barthelmes, Daniel
    Gillies, Mark
    Squirrell, David
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (09): : 1038 - 1046
  • [48] Treatment Results of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
    Choi, Yu-Jin
    Choi, Young Je
    Cho, Yong Wun
    Yoo, Woong-Sun
    Chung, In Young
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2021, 62 (09): : 1207 - 1217
  • [49] CONCEPTUAL MODELLING FOR COST-EFFECTIVENESS ANALYSIS OF INTRAVITREAL THERAPY WITH RANIBIZUMAB, AFLIBERCEPT OR BEVACIZUMAB FOR MACULAR OEDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION
    Goodall, M.
    Tosh, J.
    Alshreef, A.
    Tappenden, P.
    VALUE IN HEALTH, 2016, 19 (07) : A366 - A366
  • [50] Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
    Mesa Gutierrez, Juan Carlos
    Arias Barquet, Luis
    Caminal Mitjana, Josep Maria
    Prades Almolda, Sergi
    Planas Domenech, N-Ria
    Pujol Goita, Octavi
    Rubio Caso, Marc
    Arruga Ginebreda, Jorge
    CLINICAL OPHTHALMOLOGY, 2008, 2 (04): : 787 - 791
12345